BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1911 related articles for article (PubMed ID: 3904595)

  • 1. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological significance of the hst-1 gene.
    Terada M; Yoshida T; Sakamoto H; Miyagawa K; Katoh O; Hattori Y; Sugimura T
    Princess Takamatsu Symp; 1989; 20():71-80. PubMed ID: 2535108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH; Greenhalgh DA
    Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
    Thomassen DG; Gilmer TM; Annab LA; Barrett JC
    Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ras gene family.
    Lowy DR; Willumsen BM
    Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
    Houck KA; Michalopoulos GK; Strom SC
    Oncogene; 1989 Jan; 4(1):19-25. PubMed ID: 2783773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of oncogenes and suppressor genes in human neoplasia.
    Brodeur GM
    Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated oncogenes in human tumors.
    Suárez HG
    Anticancer Res; 1989; 9(5):1331-43. PubMed ID: 2686533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
    Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
    Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human T24 Ha-ras1 oncogene: a study of the effects of overexpression of the mutated ras gene product in rodent cells.
    Spandidos DA
    Anticancer Res; 1986; 6(2):259-62. PubMed ID: 3486626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM; Langer SJ; Ostrowski MC
    Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
    Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
    Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.
    Harris CC; Reddel R; Pfeifer A; Iman D; McMenamin M; Trump BF; Weston A
    IARC Sci Publ; 1991; (105):294-304. PubMed ID: 1855868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of human fibroblasts by oncogene transfection or carcinogen treatment.
    McCormick JJ; Fry DG; Hurlin PJ; Morgan TL; Wilson DM; Maher VM
    Prog Clin Biol Res; 1990; 340D():195-205. PubMed ID: 2196579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
    Kohl NE; Ruley HE
    Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 96.